ABBV
Income statement / Annual
Last year (2023), AbbVie Inc.'s total revenue was $54.32 B,
a decrease of 6.44% from the previous year.
In 2023, AbbVie Inc.'s net income was $4.86 B.
See AbbVie Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$54.32 B
|
$58.05 B
|
$56.20 B
|
$45.80 B
|
$33.27 B
|
$32.75 B
|
$28.22 B
|
$25.64 B
|
$22.86 B
|
$19.96 B
|
| Cost of Revenue |
$8.78 B |
$17.41 B |
$17.45 B |
$15.39 B |
$7.44 B |
$7.72 B |
$7.04 B |
$5.83 B |
$4.50 B |
$4.43 B |
| Gross Profit |
$45.54 B |
$40.64 B |
$38.75 B |
$30.42 B |
$25.83 B |
$25.04 B |
$21.18 B |
$19.81 B |
$18.36 B |
$15.53 B |
| Gross Profit Ratio |
0.84 |
0.7 |
0.69 |
0.66 |
0.78 |
0.76 |
0.75 |
0.77 |
0.8 |
0.78 |
| Research and Development
Expenses |
$8.45 B
|
$6.51 B
|
$7.08 B
|
$6.56 B
|
$6.41 B
|
$10.33 B
|
$4.98 B
|
$4.37 B
|
$4.29 B
|
$3.30 B
|
| General & Administrative
Expenses |
$10.70 B
|
$13.26 B
|
$10.25 B
|
$9.50 B
|
$5.84 B
|
$7.40 B
|
$6.28 B
|
$5.86 B
|
$6.39 B
|
$7.72 B
|
| Selling & Marketing
Expenses |
$2.20 B
|
$2.00 B
|
$2.10 B
|
$1.80 B
|
$1.10 B
|
$1.10 B
|
$846.00 M
|
$764.00 M
|
$704.00 M
|
$665.00 M
|
| Selling, General &
Administrative Expenses |
$12.87 B
|
$15.26 B
|
$12.35 B
|
$11.30 B
|
$6.94 B
|
$7.40 B
|
$6.28 B
|
$5.86 B
|
$6.39 B
|
$7.72 B
|
| Other Expenses |
$3.48 B |
$56.00 M |
$432.00 M |
-$5.61 B |
-$890.00 M |
-$18.00 M |
-$513.00 M |
-$232.00 M |
-$13.00 M |
$27.00 M |
| Operating Expenses |
$24.84 B |
$21.83 B |
$19.87 B |
$17.86 B |
$12.46 B |
$18.23 B |
$11.26 B |
$10.22 B |
$10.67 B |
$11.77 B |
| Cost And Expenses |
$41.56 B |
$39.94 B |
$38.27 B |
$34.44 B |
$20.28 B |
$26.37 B |
$18.67 B |
$16.30 B |
$15.32 B |
$16.55 B |
| Interest Income |
$540.00 M |
$186.00 M |
$39.00 M |
$174.00 M |
$275.00 M |
$204.00 M |
$146.00 M |
$82.00 M |
$33.00 M |
$38.00 M |
| Interest Expense |
$2.22 B |
$2.23 B |
$2.42 B |
$2.45 B |
$1.78 B |
$1.35 B |
$1.15 B |
$1.05 B |
$719.00 M |
$429.00 M |
| Depreciation &
Amortization |
$8.70 B
|
$8.47 B
|
$8.52 B
|
$6.47 B
|
$2.02 B
|
$1.77 B
|
$1.50 B
|
$1.19 B
|
$836.00 M
|
$786.00 M
|
| EBITDA |
$26.36 B
|
$31.42 B
|
$28.28 B
|
$21.15 B
|
$16.26 B
|
$13.69 B
|
$11.77 B
|
$10.81 B
|
$9.69 B
|
$6.29 B
|
| EBITDA Ratio |
0.49 |
0.46 |
0.47 |
0.15 |
0.41 |
0.25 |
0.39 |
0.41 |
0.37 |
0.21 |
| Operating Income Ratio
|
0.23
|
0.31
|
0.32
|
0.25
|
0.39
|
0.19
|
0.34
|
0.36
|
0.33
|
0.17
|
| Total Other
Income/Expenses Net |
-$6.51 B
|
-$4.64 B
|
-$4.94 B
|
-$7.97 B
|
-$4.56 B
|
-$1.19 B
|
-$1.82 B
|
-$1.46 B
|
-$892.00 M
|
-$1.04 B
|
| Income Before Tax |
$6.25 B |
$13.48 B |
$12.99 B |
$3.40 B |
$8.43 B |
$5.20 B |
$7.73 B |
$7.88 B |
$6.65 B |
$2.37 B |
| Income Before Tax Ratio
|
0.12
|
0.23
|
0.23
|
0.07
|
0.25
|
0.16
|
0.27
|
0.31
|
0.29
|
0.12
|
| Income Tax Expense |
$1.38 B |
$1.63 B |
$1.44 B |
$1.22 B |
$544.00 M |
$490.00 M |
$2.42 B |
$1.93 B |
$1.50 B |
$595.00 M |
| Net Income |
$4.86 B |
$11.84 B |
$11.54 B |
$4.62 B |
$7.88 B |
$5.69 B |
$5.31 B |
$5.95 B |
$5.14 B |
$1.77 B |
| Net Income Ratio |
0.09 |
0.2 |
0.21 |
0.1 |
0.24 |
0.17 |
0.19 |
0.23 |
0.23 |
0.09 |
| EPS |
2.73 |
6.65 |
6.48 |
2.73 |
5.3 |
3.69 |
3.31 |
3.65 |
3.15 |
1.11 |
| EPS Diluted |
2.72 |
6.63 |
6.45 |
2.72 |
5.28 |
3.68 |
3.3 |
3.63 |
3.13 |
1.1 |
| Weighted Average Shares
Out |
$1.77 B
|
$1.77 B
|
$1.77 B
|
$1.67 B
|
$1.48 B
|
$1.54 B
|
$1.60 B
|
$1.62 B
|
$1.63 B
|
$1.60 B
|
| Weighted Average Shares
Out Diluted |
$1.77 B
|
$1.78 B
|
$1.78 B
|
$1.67 B
|
$1.48 B
|
$1.55 B
|
$1.60 B
|
$1.63 B
|
$1.64 B
|
$1.61 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
